ArticleIn silico pharmacology2024

The combination of Curcumin and Doxorubicin on targeting PI3K/AKT/mTOR signaling pathway: an in vitro and molecular docking study for inhibiting the survival of MDA-MB-231.

Esha Sarkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.